Buscar
Mostrando ítems 1-2 de 2
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
(CANCER INTELLIGENCE LTD, 2019)
Introduction: The Gleason score is a strong prognostic factor for treatment failure in pathologically organ-confined prostate cancer (pT2) treated by radical prostatectomy (RP). However, within each Gleason score, there ...
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
(CANCER INTELLIGENCE LTD, 2019)
Introduction: 25% of Stage III colon cancer patients relapse within 5 years due to minimal residual disease (MRD) not eliminated by surgery and chemotherapy. We hypothesise that sub-types of MRD, defined by circulating ...